Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy

Overview of attention for article published in Frontiers in Medicine, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 9,730 followers.

RT @CARTTherapy: Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy https://t.co/jA2NNvq0XY

RT @CARTTherapy: Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy https://t.co/jA2NNvq0XY

RT @CARTTherapy: Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy https://t.co/jA2NNvq0XY

RT @CARTTherapy: Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy https://t.co/jA2NNvq0XY

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.